CN108187636A - A kind of preparation method of gemcitabine hydrochloride purification material - Google Patents

A kind of preparation method of gemcitabine hydrochloride purification material Download PDF

Info

Publication number
CN108187636A
CN108187636A CN201711169090.7A CN201711169090A CN108187636A CN 108187636 A CN108187636 A CN 108187636A CN 201711169090 A CN201711169090 A CN 201711169090A CN 108187636 A CN108187636 A CN 108187636A
Authority
CN
China
Prior art keywords
gemcitabine hydrochloride
abs resin
preparation
purification material
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201711169090.7A
Other languages
Chinese (zh)
Inventor
王艺霖
王新
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xiaogan Ruxi New Material Technology Co Ltd
Original Assignee
Xiaogan Ruxi New Material Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xiaogan Ruxi New Material Technology Co Ltd filed Critical Xiaogan Ruxi New Material Technology Co Ltd
Priority to CN201711169090.7A priority Critical patent/CN108187636A/en
Publication of CN108187636A publication Critical patent/CN108187636A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • B01J20/26—Synthetic macromolecular compounds
    • B01J20/264—Synthetic macromolecular compounds derived from different types of monomers, e.g. linear or branched copolymers, block copolymers, graft copolymers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

The present invention relates to a kind of preparation methods of gemcitabine hydrochloride purification material.By weight, ABS resin is added in a kettle, 4 (trimethylsiloxy group) 3 amylene, 2 ketone, 1, 1, 3, 3, 3 five fluorine 2 (fluorine methoxyl group), 1 propylene, (E) 3 [3 methyl 5 (3 methyl fourth, 2 alkenyl) imidazoles, 4 bases], the third 2 e pioic acid methyl ester, benzoyl peroxide, hydroxymethyl cellulose N, N' bis- (2 hydroxyl 5 (ethylene beta carboxyls) benzyl) ethylenediamine N, N' oxalic acid, 9, 10 2 (allyloxys) 4, 4 diethoxies 3, 8, 11 trioxa, 4 sila, 14 carbon, 13 alkene, water, it heats up after stirring evenly, reaction, product is filtered after reaction, washing, gemcitabine hydrochloride purification material is obtained after drying.

Description

A kind of preparation method of gemcitabine hydrochloride purification material
Technical field
The present invention relates to a kind of preparation method of adsorbent, especially a kind of preparation side of gemcitabine hydrochloride purification material Method.
Background technology
Gemcitabine hydrochloride be suitable for treating inoperable late period or metastatic cancer of pancreas and treatment Local advancement or Metastatic Nsclc, treatment Advanced non-small cell lung cancer, cancer of pancreas, carcinoma of urinary bladder, breast cancer and other entities swell Knurl.
CN102659884B discloses a kind of method of purification of gemcitabine hydrochloride, and step is as follows：A) by gemcitabine hydrochloride he After shore crude product is dissolved in water, adds in alkali and adjust pH value of solution to 8~9, after being stirred to react, suction filtration obtains gemcitabine；B) Jiang Jixi He is dissolved in alcoholic solvent shore, a concentration of 0.1~0.2g/mL, adds in activated carbon, and filtrate is collected in filtering；C) filtrate is utilized It prepares chromatographic column to be detached, the mobile phase that chromatographic column uses is acetone or acetonitrile and hydrochloric acid solution, acetone or acetonitrile and salt The volume ratio of acid solution is 30~50:70~50；Fixed phase stuffing is silica gel or alundum (Al2O3), collects filtrate, dry, is obtained Gemcitabine hydrochloride highly finished product.
CN101492482 discloses a kind of synthesis technology of industrial production of gemcitabine hydrochloride, belongs to chemical products synthesis Technology field.It is using 2,3- oxygen-isopentylidene-D- glyceraldehyde as raw material, through addition, open loop, cyclization, then is used respectively Intermediate is made in TBDPSCL and chlorobenzoyl chloride protection hydroxyl.Intermediate is through restoring, remove-insurance after being condensed after Mesylation with cytimidine Shield, gemcitabine hydrochloride is made into salt.
Existing gemcitabine hydrochloride is purifying link, is mostly purified, grasped using the method for crystallization or activated carbon adsorption Make relatively complicated, adsorption effect is poor.
Invention content
In order to solve the above technical problems, present invention employs following technical solutions：A kind of gemcitabine hydrochloride purification The preparation method of material, includes the following steps：
By weight, ABS resin is added in a kettle, 4- (trimethylsiloxy group) -3- amylene -2- ketone, 1,1,3,3,3- Five fluoro- 2- (fluorine methoxyl group) -1- propylene, (E) -3- [3- methyl -5- (3- methyl but-2-enes base) imidazol-4 yl] propyl- 2- olefin(e) acids Methyl esters, benzoyl peroxide, hydroxymethyl cellulose N, N'- bis- (2- hydroxyls -5- (ethylene-beta- carboxyls) benzyl) ethylenediamine N, N'- oxalic acid, 9,10- bis- (allyloxy) -4,4- diethoxies -3,8,14 carbon -13- alkene of 11- trioxa -4- silas, water, 80-100 DEG C is warming up to after stirring evenly, reacts 6-12h, product is filtered after reaction, washing, and hydrochloric acid Ji is obtained after dry His shore of west purifies material.
4- (trimethylsiloxy group) -3- amylene -2- ketone, quality dosage are the 1-3% of ABS resin.
Described 1,1,3,3,3- five fluoro- 2- (fluorine methoxyl group) -1- propylene, quality dosage are the 0.1- of ABS resin 0.5%。
Described (E) -3- [3- methyl -5- (3- methyl but-2-enes base) imidazol-4 yl] the propyl- 2- e pioic acid methyl esters, quality Dosage is the 0.5-1% of ABS resin.
The benzoyl peroxide, quality dosage are the 0.5-1.5% of ABS resin.
Its quality dosage of the hydroxymethyl cellulose is the 0.2-0.8% of ABS resin.
The N, N'- bis- (2- hydroxyls -5- (ethylene-beta- carboxyls) benzyl) ethylenediamine N, N'- oxalic acid, quality Dosage is the 0.1-0.3% of ABS resin.
The 14 carbon -13- of 9,10- bis- (allyloxy) -4,4- diethoxy -3,8,11- trioxa -4- silas Alkene, quality dosage are the 0.01-0.1% of ABS resin.
The water, quality dosage are the 300-600% of ABS resin.
The ABS resin, 4- (trimethylsiloxy group) -3- amylene -2- ketone, 1,1,3,3,3- five fluoro- 2- (fluorine methoxies Base) -1- propylene, (E) -3- [3- methyl -5- (3- methyl but-2-enes base) imidazol-4 yl] propyl- 2- e pioic acid methyl esters, benzoyl peroxide Formyl, hydroxymethyl cellulose N, N'- bis- (2- hydroxyls -5- (ethylene-beta- carboxyls) benzyl) ethylenediamine N, N'- oxalic acid, 9, 14 carbon -13- alkene of 10- bis- (allyloxy) -4,4- diethoxies -3,8,11- trioxa -4- silas, is commercial product.
Beneficial effects of the present invention：
（1）The adsorbent that the present invention is produced, endurance, heat resistance, impact resistance are strong, non-breakable, are easily isolated；
（2）Adsorbent product, adsorption capacity is strong, can save adsorption time, simplifies gemcitabine hydrochloride purifying products technique.
Specific embodiment
Embodiment 1
In a kettle, addition ABS resin 100Kg, 4- (trimethylsiloxy group) -3- amylene -2- ketone 2Kg, 1,1,3,3,3- five Fluoro- 2- (fluorine methoxyl group) -1- propylene 0.3Kg, (E) -3- [3- methyl -5- (3- methyl but-2-enes base) imidazol-4 yl] propyl- 2- E pioic acid methyl ester 0.75Kg, benzoyl peroxide 1Kg, ammonium persulfate 0.5Kg, 9,10- bis- (allyloxy) -4,4- diethoxies - 3,8,11- trioxa -4- silas, 14 carbon -13- alkene 0.05Kg, N, N'- bis- (2- hydroxyls -5- (ethylene-beta- carboxyls) benzyl) Ethylenediamine N, N'- oxalic acid 0.2Kg, water 450Kg are warming up to 90 DEG C after stirring evenly, react 9h, and product passes through after reaction Filtering, washing obtain gemcitabine hydrochloride purification material after dry.
Embodiment 2
In a kettle, addition ABS resin 100Kg, 4- (trimethylsiloxy group) -3- amylene -2- ketone 1Kg, 1,1,3,3,3- five Fluoro- 2- (fluorine methoxyl group) -1- propylene 0.1Kg, (E) -3- [3- methyl -5- (3- methyl but-2-enes base) imidazol-4 yl] propyl- 2- E pioic acid methyl ester 0.5Kg, benzoyl peroxide 0.5Kg, ammonium persulfate 0.2Kg, 9,10- bis- (allyloxy) -4,4- diethoxies - 3,8,11- trioxa -4- silas, 14 carbon -13- alkene 0.01Kg, N, N'- bis- (2- hydroxyls -5- (ethylene-beta- carboxyls) benzyl) Ethylenediamine N, N'- oxalic acid 0.1Kg, water 300Kg are warming up to 80 DEG C after stirring evenly, react 6h, and product passes through after reaction Filtering, washing obtain gemcitabine hydrochloride purification material after dry.
Embodiment 3
In a kettle, addition ABS resin 100Kg, 4- (trimethylsiloxy group) -3- amylene -2- ketone 3Kg, 1,1,3,3,3- five Fluoro- 2- (fluorine methoxyl group) -1- propylene 0.5Kg, (E) -3- [3- methyl -5- (3- methyl but-2-enes base) imidazol-4 yl] propyl- 2- E pioic acid methyl ester 1Kg, benzoyl peroxide 1.5Kg, ammonium persulfate 0.8Kg, 9,10- bis- (allyloxy) -4,4- diethoxy -3, 8,11- trioxa -4- silas 14 carbon -13- alkene 0.1Kg, N, N'- bis- (2- hydroxyls -5- (ethylene-beta- carboxyls) benzyl) second Diamines N, N'- oxalic acid 0.3Kg, water 600Kg are warming up to 100 DEG C after stirring evenly, react 12h, and product passes through after reaction Filtering, washing obtain gemcitabine hydrochloride purification material after dry.
Comparative example 1
1,1,3,3,3- five fluoro- 2- (fluorine methoxyl group) -1- propylene is added without, other conditions are the same as embodiment 1.
Comparative example 2
(E) -3- [3- methyl -5- (3- methyl but-2-enes base) imidazol-4 yl] propyl- 2- e pioic acid methyl esters are added without, other conditions are same Embodiment 1.
Comparative example 3
It is added without 9,10- bis- (allyloxy) -4,4- diethoxies -3,8,14 carbon -13- alkene of 11- trioxa -4- silas, His condition is the same as embodiment 1.
Comparative example 4
It is added without N, N'- bis- (2- hydroxyls -5- (ethylene-beta- carboxyls) benzyl) ethylenediamine N, N'- oxalic acid, other conditions are same Embodiment 1.
Embodiment 4
The thick gemcitabine hydrochloride that purity is 95% is passed through to the adsorbent made equipped with 500g embodiments 1-3 and comparative example 1-4 to produce In the 1000mL exchange columns of product, 80 DEG C, flow velocity 1BV/h of temperature, under the conditions of adsorb purification, with the matter of gas chromatographic detection efflux Percentage composition is measured, is shown in Table 1.
Table 1：Gemcitabine hydrochloride purity after the gemcitabine hydrochloride adsorbent absorption purification that different process is produced.

Claims (9)

1. a kind of preparation method of gemcitabine hydrochloride purification material, it is characterised in that include the following steps：
By weight, ABS resin is added in a kettle, 4- (trimethylsiloxy group) -3- amylene -2- ketone, 1,1,3,3,3- Five fluoro- 2- (fluorine methoxyl group) -1- propylene, (E) -3- [3- methyl -5- (3- methyl but-2-enes base) imidazol-4 yl] propyl- 2- olefin(e) acids Methyl esters, benzoyl peroxide, hydroxymethyl cellulose, N, N'- bis- (2- hydroxyls -5- (ethylene-beta- carboxyls) benzyl) ethylenediamine N, N'- oxalic acid, 9,10- bis- (allyloxy) -4,4- diethoxies -3,8,14 carbon -13- alkene of 11- trioxa -4- silas, Water is warming up to 80-100 DEG C after stirring evenly, react 6-12h, and product is filtered after reaction, and washing obtains salt after dry Sour gemcitabine purifies material.
2. a kind of preparation method of gemcitabine hydrochloride purification material according to claim 1, it is characterised in that：Described 4- (trimethylsiloxy group) -3- amylene -2- ketone, quality dosage are the 1-3% of ABS resin.
3. a kind of preparation method of gemcitabine hydrochloride purification material according to claim 1, it is characterised in that：Described 1,1,3,3,3- five fluoro- 2- (fluorine methoxyl group) -1- propylene, quality dosage are the 0.1-0.5% of ABS resin.
4. a kind of preparation method of gemcitabine hydrochloride purification material according to claim 1, it is characterised in that：Described (E) -3- [3- methyl -5- (3- methyl but-2-enes base) imidazol-4 yl] propyl- 2- e pioic acid methyl esters, quality dosage are ABS resin 0.5-1%.
5. a kind of preparation method of gemcitabine hydrochloride purification material according to claim 1, it is characterised in that：Described Benzoyl peroxide, quality dosage are the 0.5-1.5% of ABS resin.
6. a kind of preparation method of gemcitabine hydrochloride purification material according to claim 1, it is characterised in that：Described Its quality dosage of hydroxymethyl cellulose is the 0.2-0.8% of ABS resin.
7. a kind of preparation method of gemcitabine hydrochloride purification material according to claim 1, it is characterised in that：Described N, N'- bis- (2- hydroxyls -5- (ethylene-beta- carboxyls) benzyl) ethylenediamine N, N'- oxalic acid, quality dosage are ABS resin 0.1-0.3%.
8. a kind of preparation method of gemcitabine hydrochloride purification material according to claim 1, it is characterised in that：Described 9,10- bis- (allyloxy) -4,4- diethoxies -3,8,14 carbon -13- alkene of 11- trioxa -4- silas, quality dosage are The 0.01-0.1% of ABS resin.
9. a kind of preparation method of gemcitabine hydrochloride purification material according to claim 1, it is characterised in that：Described Water, quality dosage are the 300-600% of ABS resin.
CN201711169090.7A 2017-11-22 2017-11-22 A kind of preparation method of gemcitabine hydrochloride purification material Withdrawn CN108187636A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711169090.7A CN108187636A (en) 2017-11-22 2017-11-22 A kind of preparation method of gemcitabine hydrochloride purification material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711169090.7A CN108187636A (en) 2017-11-22 2017-11-22 A kind of preparation method of gemcitabine hydrochloride purification material

Publications (1)

Publication Number Publication Date
CN108187636A true CN108187636A (en) 2018-06-22

Family

ID=62572831

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711169090.7A Withdrawn CN108187636A (en) 2017-11-22 2017-11-22 A kind of preparation method of gemcitabine hydrochloride purification material

Country Status (1)

Country Link
CN (1) CN108187636A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106215895A (en) * 2016-08-21 2016-12-14 王琪宇 A kind of preparation method of gemcitabine hydrochloride purification adsorbent
CN106311168A (en) * 2016-08-21 2017-01-11 王琪宇 Preparation method for adsorbent for purifying 2-imidazolidone
CN107082884A (en) * 2017-06-04 2017-08-22 王金桢 A kind of method for adsorbing purification dimethicone

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106215895A (en) * 2016-08-21 2016-12-14 王琪宇 A kind of preparation method of gemcitabine hydrochloride purification adsorbent
CN106311168A (en) * 2016-08-21 2017-01-11 王琪宇 Preparation method for adsorbent for purifying 2-imidazolidone
CN107051395A (en) * 2016-08-21 2017-08-18 王琪宇 A kind of gemcitabine hydrochloride purifies the preparation method of auxiliary agent
CN107082884A (en) * 2017-06-04 2017-08-22 王金桢 A kind of method for adsorbing purification dimethicone

Similar Documents

Publication Publication Date Title
CN105481923B (en) A kind of preparation method of nicotinamide adenine dinucleotide
CN112870979B (en) Separation and purification method of beta-nicotinamide mononucleotide
CN106749447B (en) A kind of intermediate of epirubicin hydrochloride compound
CN107827943A (en) A kind of method that cytidine is extracted from zymotic fluid
CN110511135B (en) Method for adsorbing-separating shikimic acid by adopting chitosan
CN110078695B (en) Quercetin derivative and preparation method thereof
CN110615448B (en) Method for preparing sodium nitroprusside
CN108187636A (en) A kind of preparation method of gemcitabine hydrochloride purification material
CN107043362B (en) A kind of intermediate of epirubicin hydrochloride compounds Ⅳ
CN110128385B (en) Quercetin derivative chemically modified by lauroyl chloride and synthetic method thereof
CN105289546B (en) A kind of preparation method of liquaemin Special adsorbent
CN105949176B (en) A kind of purification process of linatinib
WO2012055253A1 (en) Regeneration method of silica gel for chromatographing coenzyme q10
CN110563778B (en) Preparation method of vitamin B12
CN107051395A (en) A kind of gemcitabine hydrochloride purifies the preparation method of auxiliary agent
CN107501375A (en) A kind of preparation method of megestrol acetate
CN108690025A (en) Utilize the method for active ingredient in acidic oxidation and alkaline reduction electric potential water extraction kuh-seng
CN106905320A (en) It is a kind of to be adapted to medicinal replace Buddhist nun and its preparation according to Shandong
CN106188140B (en) A kind of synthesis technique of Aldoforwe ester
CN104610202B (en) A kind of arginic preparation method of vitamin C
CN107029681A (en) A kind of lactate purifies the preparation method of auxiliary agent
CN111004300B (en) Method for preparing Sofosbuvir
CN113717118B (en) Synthesis process of valsartan
CN112552230B (en) Synthetic method of cyproheptadine hydrochloride
CN108192026A (en) A kind of preparation method of propylene oxide purification material

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20180622